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STEAROYL-COA DESATURASE (SCD1) is an endoplasmic reticulum iron-containing microsomal enzyme required for endogenous formation of monounsaturated fatty acids (MUFA) from saturated fatty acid (SFA) substrates. SCD1 converts SFA to MUFA by incorporating a double bond between the 9th and 10th carbons of long-chain fatty acyl-CoAs, mainly in stearoylCoA (18:0) or palmitoyl-CoA (16:0), to generate oleoyl-CoA (18:1n9) or palmitoleoyl-CoA (16:1n9), respectively (16) . The desaturation reaction requires NADH/NAD ϩ , cytochrome b6, cytochrome b6 reductase, and oxygen (16) .
SCD1 is a rate-limiting enzyme found in mammals that is essential for the conversion of endogenous and exogenous SFA into MUFA. There have been two isoforms identified in humans (SCD1 and SCD5), four identified in mice (SCD1, SCD2, SCD3, and SCD4), and two in rats (SCD1 and SCD2) (85) . The SCD1 isoform is highly expressed in skeletal muscle and appears to influence fatty acid composition, lipid esterification, lipogenesis, and ␤-oxidation, all of which indirectly influence glucose uptake and insulin signaling. However, the majority of research involving SCD1 has focused much more on hepatic SCD1 expression and not expression in muscle.
Desaturation Index and Fatty Acid Composition as Indirect Indicators for SCD1 Skeletal Muscle Expression
While there is a scarcity of data that exclusively focuses on SCD1 expression in muscle (Table 1) , inferences can be made about muscle SCD1 expression when assessing certain surrogate markers. These inferences on expression of SCD1 include the analysis of fatty acid composition and desaturation indexes (DI) in exercise-trained vs. sedentary groups and lean and obese populations. There are also data assessing how macronutrient ratios and overall caloric intake may affect DI and fatty acid composition, which may be used to infer SCD activity. Measuring fatty acid composition along with DI is a unique method to interpret estimated expression of SCD1, as fatty acid composition may indirectly demonstrate the degree of esterification and types of de novo lipogenic products being synthesized, while the DI displays how SCD activity affect MUFA/SFA ratio. Caution should be taken, as exogenous lipid incorporation into various lipid classes can confound the interpretation of DI and fatty acid composition. Moreover, certain unsaturated fatty acids appear to have the ability to alter muscular DI through different mechanisms of action (5, 83) . However, if macronutrient intake patterns are the same between groups, it is then possible to make inferences based on DI or other surrogate markers of SCD activity (26) .
Body Composition and Activity Level Alter SCD1 Expression in Skeletal Muscle
Differences have been observed when SCD1 expression in muscle of lean and obese groups is being assessed. SCD1 expression has been shown to be elevated in obese human subjects (29) . Increased SCD1 expression was correlated with changes in fatty acid composition of glycerolipids with increased oleic acid and lower palmitic acid (16:0) and stearic acid (18:0) compared with lean subjects (29) . The DI (16:1/ 16:0 and 18:1/18:0) was also higher in the obese group compared with the lean group (29) . Interestingly, increased expression of SCD1 in obese subjects correlated with decreased ␤-oxidation. This effect was determined by overexpressing SCD1 in primary myocytes obtained from lean donors, which increased accumulation of triglycerides (TG) (29) . High SCD1 expression has also been observed in obese rodent models. Zucker rats have a missense mutation in the leptin receptor that causes impaired leptin signaling (59) , resulting in hyperphagia and obesity (10) . Moreover, these animals develop ␤-cell dysfunction that reduces insulin levels (77) , which may influence SCD1 expression. Male Zucker rats have exhibited increases of SCD1 in muscle corresponding to a higher content of palmitoleic acid (16:1n9) compared with lean rats (84) .
A single bout of aerobic exercise has been shown to increase skeletal muscle protein concentrations of SCD1 in human subjects (70) . Chronic aerobic exercise influences SCD1 protein levels in humans, too. A study involving endurance-trained athletes and lean sedentary and obese sedentary subjects was conducted to evaluate differences in SCD1 protein content (3). SCD1 protein expression was significantly higher in athletes compared with both sedentary groups (3) . Evidence has also demonstrated that endurance athletes have increased intramyocellular triglycerides (IMTG) (22) and that exercise increases both ␤-oxidation (78) and lipogenesis (31) within muscle. All of these factors may at least partially explain what is known as "the athlete's paradox". This is a phenomenon commonly found in well-trained aerobic athletes who have high levels of IMTG and are highly insulin sensitive, which contrasts with obese individuals that have high IMTG content but are insulin resistant (73) .
A study using female mice undergoing a swimming regimen for 2 wk assessed SCD1 mRNA levels in gastrocnemius and quadriceps muscles. Mice in the swimming group had dramatically higher SCD1 mRNA expression in quadriceps and gastrocnemius 3 h postexercise, as determined by Northern blotting, which persisted for over 22 h (31) . SCD1 expression is highest in type I oxidative fibers (14) , with soleus and red gastrocnemius composed predominantly of type I and quadriceps and white gastrocnemius composed predominantly of type II (67, 68) . This is significant due to the fact that an increase in SCD1 expression in most tissues is extremely transient and both mRNA and protein half-life is only a few hours (24, 50, 54) .
Another study involving male rats performing treadmill aerobic exercise has demonstrated considerably higher SCD1 protein and mRNA concentrations in the soleus muscle compared with their sedentary counterparts (18) . Consistent with these findings are the observations in soleus that the DI (18:1/18:0) and free fatty acid (FFA), diacylglycerol (DAG), and TG levels were higher in the endurance-trained rats, with no changes in the extensor digitorum longus (EDL) muscle. The FFA, DAG, and TG lipid fractions in the soleus of the endurance-trained rats were also associated with high levels of unsaturated fatty acids. It is plausible to assume that differences between muscle groups is due largely to muscle fiber type, as EDL is known as a glycolytic tissue (33) whereas the soleus is mainly oxidative (58) . Oxidative fibers rich in IMTG may act as a localized energy reservoir during long bouts of aerobic training when working muscles need sustained energy via ␤-oxidation. Therefore, high SCD1 expression would be beneficial for endurance exercise, as it would allow an increase of IMTG content in working skeletal muscle.
Role of SCD1 in Insulin Signaling and Sensitivity within Skeletal Muscle
SCD1 global knockout (gKO) mice have demonstrated marked increases in insulin signaling in liver, adipose, and muscle. SCD1 gKO mice are genetically modified to lack SCD1 expression in all tissues. Rahman et al. found increased glycogen synthase and glycogen phosphorylase activation, increased GLUT4 content, and elevations in insulin receptor tyrosine phosphorylation along with increases in insulin receptor substrates 1 and 2 of SCD1 gKO mice (64) . These mice also exhibited a significant increase in 5=-adenosine monophosphate-activated protein kinase (AMPK) activation (17) . Furthermore, SCD1 gKO mice display a dramatic rise in thermogenesis, ␤-oxidation, and insulin sensitivity in skeletal muscle along with other tissues, in addition to a substantial decrease in lipid synthesis in various cell types, including skeletal myocytes (21) . Surprisingly, these metabolic consequences are not considered to be the result of SCD1 deletion in skeletal muscle, liver, or adipose tissue, but rather it has been attributed to loss in the skin. Skin knockout (SKO) mice display many of the antiobesity phenotypes seen in the gKO model including increased insulin sensitivity in muscle (69) . SCD1 SKO mice are different from SCD1 gKO mice as SCD1 deletion is specific to skin, and SCD1 expression is present in all other tissues. SKO mice are cold intolerant due to depleted glycogen stores in liver and likely muscle, although the latter was not assessed (69) . For these reasons, inferences about specific SCD1 deletion in skeletal muscle may not be appropriate when data from gKO mice are being evaluated. At the very least, it should be viewed with caution. Although data support that insulin signaling and sensitivity are increased in SCD1 gKO mice (64) , it actually impairs proper insulin function in SCD1 gKO obese diabetic mouse models (20) . Leptin-deficient ob/ob mice lacking SCD1 have impaired fasting glucose, poor insulin output, and glucose intolerance, which reduced the time to development of insulin resistance in these mice (20) . Those authors speculated that the cause of hyperglycemia was due to negative alterations in ␤-cells of the pancreas. These disturbances included high levels of TG, FFAs, SFA, and both free and esterified cholesterol coinciding with decreased insulin content in these cells (20) . Paradoxically, muscle insulin resistance has been observed in diabetic rat models with high SCD1 expression in skeletal muscle (84) . This effect is also noted in obese humans (29) , whereas endurance athletes have high SCD1 expression (4) and increased insulin sensitivity (4, 22) .
SCD1 and Skeletal Muscle Lipotoxicity
SFA can cause cellular stress and inflammation through several different mechanisms (13, 27, 28, 36, 38, 45, 61, 72, 87) . SCD1 may reduce proinflammatory signaling by increasing SFA conversion into MUFA (Fig. 1) . It is generally accepted that SFA, in particular palmitic acid and stearic acid, are considered lipotoxic to cells (51) and promote insulin resistance (30, 81) . The result of lipotoxicity can trigger endoplasmic reticulum (ER) stress in addition to inflammation, which is caused by cytokine expression (55) . Long-chain SFA activates toll-like receptor 4 (TLR4) (7), which also results in ER stress and a proinflammatory response (46) . However, the ability of palmitic acid to induce insulin resistance was markedly lower when TLR4 was inhibited in rat L6 myotubes (63) . Results from the same study also discovered that TLR4-null mice (C57/B10 ScN) were significantly protected from lipidinduced insulin resistance (63) . High SCD1 expression may be beneficial in regard to reducing SFA that may activate TLR4. While it has been shown that increased expression of SCD1 in skeletal muscle cells exposed to palmitic acid rescues them from lipotoxicity and insulin resistance by reducing inflammation and ER stress (55) , future studies should be conducted to determine whether SCD1 expression may reduce TLR4 activation in skeletal muscle.
Fatty Acids and Energy Balance Influencing SCD1 Skeletal Muscle Expression
Unlike obesity or exercise, polyunsaturated fatty acids (PUFA) decrease SCD1 expression in skeletal muscle. A study Diminished SCD1 activity can result in increased levels of saturated fatty acids (SFA), which reduces TG and increases diacylglycerol (DAG) levels. SFA that is incorporated into a saturated DAG results in a completely saturated TG (i.e., sn1,3 palmitoyl, 2-stearoyl glycerol) that is less fluid than MUFA containing TG (i.e., sn1,3 palmitoyl, 2-oleoyl glycerol). SFA can also trigger inflammation and de novo ceramide synthesis, initiating insulin resistance. High SCD1 activity may result in insulin sensitivity, though, by converting stearic acid into oleic acid, which is easily incorporated into TG that promotes lipid droplet synthesis. This effect of SCD1 results in reducing cell stress, restoring insulin signaling, improving glucose tolerance, decreasing ceramide synthesis, and preventing apoptosis.
conducted by Lee et al. (37) reported that SCD1 mRNA increased with a high SFA diet but not with a high PUFA diet. Furthermore, SCD1 protein expression in skeletal muscle was significantly lower in rats fed a high PUFA diet (37) . MUFA appears to decrease SCD1 expression in vitro, although results between cell culture and in vivo experiments are not conclusive. Oleic acid (18:1n9) preincubation of C 2 C 12 myoblasts that were exposed to palmitic acid resulted in lower SCD1 mRNA (25) . This evidence may indicate that SCD1 expression may be affected by the presence of its substrates and may be feedback inhibited. Evidence has shown that artificially inducing SCD1 expression in myotubes from lean donors results in a phenotype that is similar to obese models (29) . Additionally, data have demonstrated that overexpression of SCD1 protects against fatty acid-induced insulin resistance in vitro (62) . Moreover, results have shown that there is no difference in SCD1 protein expression in lean and obese humans (75) . Therefore, future studies need to test whether SCD1 expression in skeletal muscle is a causal factor in the development of insulin resistance and glucose intolerance or whether increased SCD1 expression is simply the result of obesity and only positively correlated with it.
Role of SCD1 in Skeletal Muscle Fatty Acid Oxidation, Lipogenesis, and Esterification
Endurance athletes have been shown to display high SCD1 expression and IMTG content (4, 22) , and elevated SCD1 expression may promote increased MUFA content of IMTG and cell membrane fluidity. A membrane DI with an increased MUFA/SFA ratio is known to allow appropriate fluidity of the lipid bilayer (12, 27, 52) . It is not completely understood why increased SCD1 levels in obese individuals are positively correlated with insulin resistance whereas high SCD1 expression in athletes is associated with insulin sensitivity (Fig. 2) . This might be partially attributed to decreased ␤-oxidation within skeletal muscle as a result of obesity (29), while aerobically trained athletes display increased ␤-oxidation (22, 49) . Increased ␤-oxidation in endurance athletes may allow IMTG to have a high turnover rate that permits greater flexibility. This is in contrast to obese sedentary individuals, who are metabolically inflexible and have a low IMTG turnover rate, which may contribute to the pathogenesis of insulin resistance (82) . The increase in ␤-oxidation with physical activity is due in part to increased AMPK activation (9, 19, 44, 65) , which leads to upregulation of SCD1 expression (18) . Conversely, a different trend is observed in vitro, as SCD1 overexpression in myocytes from lean donors has resulted in a decrease of AMPK phosphorylation (29) . However, it should be noted that exercise increases AMPK because it consumes ATP to generate AMP. Cells in culture do not "exercise" and most likely do not have an increase in AMP production, which may explain the limited AMPK activity in vitro.
Data from SCD1 gKO mice have shown increases in the activation of AMPK in type I oxidative fibers but not in type II Fig. 2 . Pathway of exogenous (dietary) FFA entry into ␤-oxidation. Dietary FA is esterified as TG then incorporated into lipid droplets for storage. When needed as fuel, TG is hydrolyzed via ATGL expressed in skeletal muscle, HSL, and MAGL to liberate FA that are reesterified to CoA via ACS. It is now believed that incorporation into lipid droplets is necessary for dietary FA to enter mitochondria for ␤-oxidation. This theory proposes that dietary FA do not enter directly into the mitochondria without channeling through lipid droplet synthesis. Therefore, any dietary FAs that enhance the lipid droplet formation rate would also be expected to increase the fat oxidation rate. Since SCD1 results in conversion of SFA into MUFA that be easily be incorporated into TG, high SCD1 expression may enhance the rate of ␤-oxidation. ACS, acyl-CoA synthetase; AGPAT, acyl-CoA:acylglycerol-3-phosphate acyltransferase; ATGL, adipose triglyceride lipase; DAG, diacylglycerol; DGAT, diacylglycerol acyltransferase; FA-CoA, fatty acyl-CoA; GPAT, glycerol-3-phosphate acyltransferase; HSL, hormonesensitive lipase; LPA, lysophosphatidic acid; LPL, lipoprotein lipase; MAG, monoacylglycerol; MAGL, monoacylglycerol lipase; PA, phosphatidic acid; PAP, PPAR, peroxisome proliferator-activated receptor. glycolytic muscles (15) . The investigators speculated that increased AMPK activation in the oxidative fibers may induce fatty acid ␤-oxidation in SCD1 gKO mice. An increase in carnitine palmitoyltransferase-1 (CPT-1) was observed in the type I oxidative fibers of SCD1 gKO mice as well (15) . This may further increase ␤-oxidation in SCD1 gKO mice and play a role in the hypermetabolic phenotype (6) . Furthermore, it has been noted that O 2 consumption is chronically elevated during fasting and feeding phases in SCD1 gKO mice, which signifies higher energy expenditure and may indicate more fatty acid oxidation in these animals (53) . Not only does ␤-oxidation appear to be increased in SCD1 gKO mice, but lipogenesis appears to be reduced as well (53) . This suggests that enhanced ␤-oxidation in skeletal muscle of SCD1 gKO mice allows SFA to become oxidized instead of accumulating in muscle tissue, thus preventing the detrimental effects of SFA-induced lipotoxicity.
It is questionable how large a role de novo lipogenesis from carbohydrate sources plays in skeletal muscle itself. In vitro studies have shown that de novo lipogenesis plays a central role in lipid accumulation in muscle when hyperglycemic conditions are present. Accumulation of lipid was observed in rat skeletal muscle after a 24-h treatment with 25 mM glucose (23) . Additionally, human muscle treated with 20 mM glucose for 4 days resulted in TG accumulation (1) . The actual amount of IMTG appears to be minimal when directly synthesized from skeletal muscle, as well as the rates of de novo lipogenesis, when compared with adipocytes and hepatocytes in vivo (32, 74, 88) . Therefore, future research needs to be conducted to evaluate the importance of skeletal muscle de novo lipogenesis in vivo as well as what role, if any, SCD1 plays in this process.
It is clear that an increase in IMTG content of endurance athletes may be due to SCD1 playing a role in TG formation. It has been suggested that MUFA (or at least a percentage of total lipid as MUFA) is critical for the efficient production of TG (47, 48) . MUFA generated by SCD1 supports TG synthesis (40) , with SCD1 being in direct physical contact with acylCoA:diacylglycerol acyltransferase-2 (DGAT2) (42) . Increased SCD1 has also been shown to increase SFA desaturation that enhances TG esterification (56) . These effects have been observed in both in vitro and in vivo studies. Overexpression of SCD1 in rat myotubes caused an increase in MUFA synthesis as well as an increase in TG production. These changes were also observed with a concomitant reduction in of ceramide and DAG levels (62) . In humans, acute exercise increased SCD1 and raised IMTG synthesis while lowering DAG and reducing inflammation (70) . Increasing MUFA production appears to enhance the rate of TG formation and may result in reduced lipotoxicity and improvements in insulin signaling. Increasing TG formation via SCD1 expression may also result in an increase in ␤-oxidation by enhancing lipid storage.
SCD1 Expression Regulates Ceramide Synthesis in Skeletal Muscle
SCD1 can have a profound effect on fatty acid composition within skeletal muscle (Table 2 ). Increased SCD1 expression may not only be beneficial in converting SFA into MUFA, but may also decrease ceramide accumulation. De novo synthesis of ceramides in humans is regulated by six ceramide synthases (57) . In skeletal muscle, ceramide synthase-1, which synthesizes ceramides with stearoyl-CoA, is the predominant form of ceramide synthase (34) . Other synthases that synthesize ceramides with palmitoyl-CoA are also present within skeletal muscle (39) . High SCD1 activity reduces the flux of SFA through ceramide synthases by converting them (SFA) into MUFA. Conversely, decreasing SCD1 activity allows MUFA to accumulate, resulting in increased flux into ceramide synthesis pathways and ceramide accumulation in muscle tissue.
Synthesis of ceramides in human skeletal muscle from palmitic acid exposure has been shown to trigger insulin resistance (2, 60, 71) . A study involving lean athletes, lean sedentary subjects, and obese participants analyzed fatty acid composition and discovered that total, saturated, and unsaturated ceramide levels within skeletal muscle were found to be significantly higher in the obese group than in both lean subjects and athletes (3). Additionally, SCD1 protein levels in the study showed a positive relationship with insulin sensitivity, whereas negative correlations were observed with total, saturated, and unsaturated ceramides (3) . A surprising finding of the study was that DAG, which is thought to promote skeletal muscle insulin resistance (76) , was higher in the athletes than in the sedentary lean and obese subjects, leading researchers of the study to assume that the "athlete's paradox" may be even more complicated than originally expected (i.e., not exclusively restricted to TG) (3).
Total DAG content may not be detrimental in itself, but instead certain DAG species may be lipotoxic (3). These results, along with an in vitro study using mouse myocytes exposed to SFA, demonstrated that ceramide accumulation, not DAG accumulation, impaired insulin signaling pathways (8) . Moreover, siRNA-mediated knockdown of SCD1 in L6 rat myotubes resulted in a dramatic increase in ceramide concentration after 5-h exposure to SFA (79) . Interestingly, the same study also demonstrated that SCD1 knockdown raised ceramides when treated for 5 h in a fatty acid-free medium (79) . It was suggested that SCD1 inhibition could cause apoptosis by inducing ceramide synthesis. Conversely, SCD1 gKO mice have been shown to have a markedly lower ceramide concentration in oxidative muscle (15) . However, this effect may be largely due to serine palmitoyltransferase (SPT) reduction in oxidative fibers along with increased ␤-oxidation (15).
Future Directions
There has been a paucity of research conducted on SCD1 in skeletal muscle, especially compared with hepatic SCD1 expression. However, in the few studies to date, physical activity has demonstrated a strong influence on SCD1 expression in mice (31) , rats (18) , and humans (4, 22) . Acute bouts of aerobic training can positively influence SCD1 expression and activity (70) . Additionally, chronic endurance exercise has also demonstrated increased levels of SCD1 in skeletal muscle (3) , which may at least partially explain the "athlete's paradox" commonly seen in endurance athletes (3) .
Our laboratory recently completed a project involving an SCD1 transgenic mouse model that overexpresses SCD1 specifically in skeletal muscle (SCD1 Tg) (66) . When fed standard chow, results from this study showed that these animals had reduced levels of SFA in their muscle along with increased MUFA compared with control mice, as expected. A surprising finding, though, was that SCD1 Tg mice demonstrated significantly higher PUFA content in muscle TG. These differences in markedly higher PUFA accumulation were attributed to higher food intake and elevated energy expenditure compared with control mice. SCD1 Tg mice also displayed an approximately 2.5-fold increase in IMTG content. The increased TG synthesis was due, in part, to elevated esterification capacity via the de novo lipogenic transcription factor sterol regulatory element-binding protein-1c, fatty acid elongase, and DGAT2. Mitochondrial content was assessed in SCD1 Tg animals and found to be over twofold higher in red muscle fibers. The increased mitochondrial content translated into an increased ability to oxidize 14 C-labeled stearic acid in ex vivo cultured skeletal muscle. SCD1 animals also demonstrated a very large increase in endurance exercise capacity, which may have been partially due to increased mitochondrial content and PPAR␦ expression (66) . Evidence demonstrates that insulin resistance directly correlates with increased SFA within IMTG (43) , whereas MUFA prevents insulin resistance initiated by SFA in skeletal muscle (11) . Therefore, SCD1 may offer protection against hyperlipidemia and skeletal muscle insulin resistance via increasing MUFA incorporation into IMTG. Future in vitro and in vivo studies should be conducted to determine how dietary fats and carbohydrates affect SCD1 expression in skeletal muscle. While studies have analyzed how hepatic SCD1 is affected by dietary macronutrients, research assessing dietary regulation of SCD1 within muscle is scarce. Furthermore, attempting to confirm the importance of skeletal muscle de novo lipogenesis and SCD1's role in muscle lipid synthesis is needed. Future studies need to be performed to determine whether skeletal muscle de novo lipogenic pathways are a prominent player in glucose metabolism. Finally, increasing skeletal muscle lipogenesis via SCD1 activation may protect against lipotoxicity and cell stress (80) .
Summary
SCD1 is a unique enzyme that appears to influence lipid bilayer fluidity, lipogenesis, fatty acid oxidation, lipotoxicity, and glucose homeostasis in skeletal muscle. SCD1 may positively alter lipid bilayer fluidity by promoting a proper ratio of MUFA/SFA in the cell membrane via SFA conversion to MUFA. SCD1 is also known to be critical to lipogenesis, since SCD1 is involved in the de novo lipogenic pathway. Whether de novo lipogenesis occurring directly within skeletal muscle is Zucker diabetic fatty rats displayed hyperinsulinemia, hyperglycemia, hypertriglyceridemia, hyperleptinemia, and elevated Hb A1c levels. Male Sprague-Dawley rats fed an eightweek high-SFA diet, high-PUFA diet, or control diet for eight weeks (37) Highest in high-SFA diet TG (total and percent unsaturated fatty acids) were highest in high-PUFA diet, while total DAG and percent saturated fatty acids within TG were highest in high-SFA diet
Compared to control diet, high-SFA diet decreased glucose tolerance, while high-PUFA diet increased insulin sensitivity
Male Wistar rats performing a sixweek treadmill program compared to sedentary controls (18) Increased in soleus in exercisetrained rats but remained unchanged in EDL FFA, DAG, and TG increased in soleus of exercise-trained rats but remained unchanged in EDL PPAR␥, PPAR␦, acetyl-CoA carboxylase, fatty acid synthase, GPAT, and DGAT all increased in the soleus of exercise trained rats DAG, diacylglycerol; TG, triglyceride; SFA, saturated fatty acid; PPAR, peroxisome proliferator-activated receptor; GPAT, glycerol-3-phosphate acyltransferase; DGAT, acyl-CoA:diaclyglycerol acyltransferase.
imperative, however, remains to be elucidated. Lipotoxicity may be reduced in muscle with increased SCD1 expression by decreasing SFA and SFA-derived products (i.e., ceramides). While fatty acid oxidation and insulin sensitivity and signaling are increased in SCD1 gKO mice, the effects of a specific SCD1 skeletal muscle KO are not currently known. High expression of SCD1 in the muscle of aerobically trained athletes, though, favors insulin sensitivity that corresponds to increases in both ␤-oxidation and lipogenesis. Interestingly, high expression of SCD1 in obese sedentary individuals correlates with high lipogenesis, low ␤-oxidation, and insulin resistance. Therefore, research attempting to extrapolate why obese sedentary subjects and lean endurance-trained athletes both display high SCD1 expression in muscle but have such vast differences in metabolism should be performed.
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